HYPR OBI Trademark

Trademark Overview


On Tuesday, January 28, 2025, a trademark application was filed for HYPR OBI with the United States Patent and Trademark Office. The USPTO has given the HYPR OBI trademark a serial number of 99020582. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 22, 2025. This trademark is owned by OBI PHARMA, INC.. The HYPR OBI trademark is filed in the Pharmaceutical Products category with the following description:

Immunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorga...
hypr obi

General Information


Serial Number99020582
Word MarkHYPR OBI
Filing DateTuesday, January 28, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, October 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedThe color(s) black and teal is/are claimed as a feature of the mark.
Goods and ServicesImmunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorganisms for medical purposes
Description of MarkThe mark consists of the stylized wording "HYPR OBI". The wording "HYPR" is in black and "OBI" is in teal. There is a curved teal line below "OBI". The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOBI PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City
TW

Trademark Events


Event DateEvent Description
Tuesday, January 28, 2025NEW APPLICATION ENTERED
Tuesday, January 28, 2025APPLICATION FILING RECEIPT MAILED
Monday, June 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 30, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 8, 2025ASSIGNED TO EXAMINER
Thursday, July 24, 2025NON-FINAL ACTION WRITTEN
Thursday, July 24, 2025NON-FINAL ACTION E-MAILED
Thursday, July 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 22, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED